P

Inventor

OKUHARA MASAKUNI

JP41 patents
⚠️ This page may combine multiple inventors who share the name “OKUHARA MASAKUNI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

FUJISAWA PHARMACEUTICAL CO

39 patents
US4894366AJan 16, 1990

Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same

FUJISAWA PHARMACEUTICAL CO214 citations99
US4929611AMay 29, 1990

Method for immunosuppression

FUJISAWA PHARMACEUTICAL CO105 citations97
US5624842AApr 29, 1997

Strain of Streptomyces for the production of tricyclo compounds

FUJISAWA PHARMACEUTICAL CO35 citations96
US5496727AMar 5, 1996

Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same

FUJISAWA PHARMACEUTICAL CO22 citations96
US4956352ASep 11, 1990

Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same

FUJISAWA PHARMACEUTICAL CO48 citations96
US5376634ADec 27, 1994

Polypeptide compound and a process for preparation thereof

FUJISAWA PHARMACEUTICAL CO57 citations95
US4977138ADec 11, 1990

FR901228 substance and preparation thereof

FUJISAWA PHARMACEUTICAL CO92 citations95
US5254562AOct 19, 1993

Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same

FUJISAWA PHARMACEUTICAL CO25 citations92
US5187195AFeb 16, 1993

Anthraquinone derivatives and preparation thereof

FUJISAWA PHARMACEUTICAL CO45 citations90
US6028097AFeb 22, 2000

Method of immunosuppression

FUJISAWA PHARMACEUTICAL CO8 citations82
US5830717ANov 3, 1998

Process for production of tricyclo compounds with streptomyces

FUJISAWA PHARMACEUTICAL CO9 citations82
US5565559AOct 15, 1996

Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same

FUJISAWA PHARMACEUTICAL CO8 citations82
US5110811AMay 5, 1992

Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same

FUJISAWA PHARMACEUTICAL CO20 citations82
US5037809AAug 6, 1991

Antimicrobial agent, FR109615 and production thereof

FUJISAWA PHARMACEUTICAL CO15 citations80
US6482845B1Nov 19, 2002

Method for inhibiting interleukin-2 production using tricyclo compounds

FUJISAWA PHARMACEUTICAL CO2 citations74
US6201005B1Mar 13, 2001

Method for inhibiting lymphokine production

FUJISAWA PHARMACEUTICAL CO5 citations74
US5266692ANov 30, 1993

Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same

FUJISAWA PHARMACEUTICAL CO12 citations74
US6110933AAug 29, 2000

Amino acid derivatives and their use as phospholipase A2 inhibitor

FUJISAWA PHARMACEUTICAL CO9 citations73
US5447854ASep 5, 1995

Production of cyclosporin A and/or C with a strain of NECTRIA

FUJISAWA PHARMACEUTICAL CO7 citations73
US5502033AMar 26, 1996

Antimicrobial polypeptide compound a pharmaceutical composition comprising the same, and a method for treating infectious diseases

FUJISAWA PHARMACEUTICAL CO10 citations72
US5061730AOct 29, 1991

Carboxylic acid derivatives

FUJISAWA PHARMACEUTICAL CO6 citations72
US5545542AAug 13, 1996

WB2663 substances and method for their production

FUJISAWA PHARMACEUTICAL CO13 citations71
US5514715AMay 7, 1996

Antimicrobial agent, FR109615 and production thereof

FUJISAWA PHARMACEUTICAL CO8 citations71
US5279826AJan 18, 1994

Prophylactic/therapeutic composition for disseminated intravascular coagulation, chronic respiratory tract infectious disease or chronic bronchitis

FUJISAWA PHARMACEUTICAL CO6 citations69
US5409701AApr 25, 1995

FR901451 substance, process for preparation thereof and use thereof

FUJISAWA PHARMACEUTICAL CO5 citations63
US5547934AAug 20, 1996

WF11243 substance

FUJISAWA PHARMACEUTICAL CO3 citations62
US5446022AAug 29, 1995

WF11243 substance

FUJISAWA PHARMACEUTICAL CO2 citations62
US5364624ANov 15, 1994

WS7622A mono- or di-sulfate, process for preparation thereof and use thereof

FUJISAWA PHARMACEUTICAL CO2 citations62
US5292510AMar 8, 1994

WS7622A mono- or di- sulfate, process for preparation thereof and use thereof

FUJISAWA PHARMACEUTICAL CO2 citations62
US5167958ADec 1, 1992

WS7622A, B, C and D substances, derivatives thereof, processes for preparation thereof and use for treatment of pulmonary emphysema and adult respiratory distress syndrome

FUJISAWA PHARMACEUTICAL CO3 citations62
US5043354AAug 27, 1991

Pharmaceutically useful 5-hydroxy-2,3-dihydro-benzofurans and 5-hydroxy-benzofurans

FUJISAWA PHARMACEUTICAL CO5 citations62
US5021240AJun 4, 1991

WS7622A, B, C and D substances, derivatives thereof, processes for preparation thereof and use thereof

FUJISAWA PHARMACEUTICAL CO5 citations62
US4143135AMar 6, 1979

Antibiotic phosphonic acid derivatives and production and use thereof

FUJISAWA PHARMACEUTICAL CO2 citations62
US5436140AJul 25, 1995

Process for producing WS-9326A and WS-9326B

FUJISAWA PHARMACEUTICAL CO4 citations61
US4680178AJul 14, 1987

Antitumor agent comprising FR-900216

FUJISAWA PHARMACEUTICAL CO2 citations61
US5217952AJun 8, 1993

Peptides WS-9326a and WS-9326b, derivatives thereof and uses thereof

FUJISAWA PHARMACEUTICAL CO2 citations51
US4963585AOct 16, 1990

Compound, WF11605 and derivative thereof

FUJISAWA PHARMACEUTICAL CO0 citations51
US4939241AJul 3, 1990

Amino acid derivatives of antitumor activity

FUJISAWA PHARMACEUTICAL CO1 citations51
US4910017AMar 20, 1990

New compounds WF 2015 A and B

FUJISAWA PHARMACEUTICAL CO0 citations40

(unassigned)

1 patent

RILIS CO LTD

1 patent